Longitudinal Evaluation of the Novel Psoriatic Arthritis 5-Thermometer Scale (PsA-5Ts) Domains During Treatment with Guselkumab: Pooled Analysis of Three Phase 3, Randomized, Double-blind, Placebo-Controlled Studies

被引：0
|
作者：
Selmi, Carlo [1 ]
Salaffi, Fausto [2 ]
Aydin, Sibel [3 ]
Soriano, Enrique [4 ,5 ]
Rampakakis, Emmanouil [6 ]
Sharaf, Mohamed [7 ]
Zimmermann, Miriam [8 ]
Lavie, Frederic [9 ]
Nash, Peter [10 ]
Mease, Philip J. [11 ,12 ]
机构：
[1] Humanitas Univ, Humanitas Res Hosp, Rheumatol & Clin Immunol, Internal Med, Rozzano, Italy
[2] Polytech Univ Marche, Carlo Urbani Hosp, Dept Clin & Mol Sci, Ancona, Italy
[3] Ottawa Hosp Riverside Campus, Dept Med, Ottawa, ON, Canada
[4] Hosp Italiano Buenos Aires, Internal Med Serv, Rheumatol Sect, Buenos Aires, DF, Argentina
[5] Univ Inst Hosp Italiano Buenos Aires, Buenos Aires, DF, Argentina
[6] McGill Univ, Dept Pediat, Sci Affairs, JSS Med Res, Montreal, PQ, Canada
[7] Janssen MEA, Immunol, Dubai, U Arab Emirates
[8] Janssen Med Affairs LLC, Immunol, Zug, Switzerland
[9] Johnson & Johnson, Janssen Pharmaceut Co, Paris, France
[10] Griffith Univ, Sch Med, Brisbane, Qld, Australia
[11] Providence St Joseph Hlth, Swedish Med Ctr, Seattle, WA USA
[12] Univ Washington, Sch Med, Seattle, WA USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2023年 / 75卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1429
引用
收藏
页码：2809 / 2811
页数：3
相关论文
共 50 条
  • [41] Consistent and significant improvement of nighttime voiding frequency (nocturia) with silodosin in men with LUTS suggestive of BPH: pooled analysis of three randomized, placebo-controlled, double-blind phase III studies
    Eisenhardt, Andreas
    Schneider, Tim
    Cruz, Francisco
    Oelke, Matthias
    WORLD JOURNAL OF UROLOGY, 2014, 32 (05) : 1119 - 1125
  • [42] Evaluation of cardiovascular risks in adult patients with episodic or chronic migraine treated with galcanezumab: data from three phase 3, randomized, double-blind, placebo-controlled studies
    Oakes, T. M.
    Kovacs, R.
    Rosen, N.
    Doty, E. G.
    Kemmer, P.
    Aurora, S. K.
    Camporeale, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 295 - 295
  • [43] LONG-TERM EFFICACY OF GUSELKUMAB IN FATIGUE AND IDENTIFICATION OF EARLY TREATMENT TARGETS: POST HOC ANALYSIS THROUGH 2 YEARS OF A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY CONDUCTED IN BIOLOGIC-NAIVE PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS
    Gladman, D. D.
    Starr, M.
    Ranza, R.
    Bravo Perdomo, A. M.
    Strauss, M.
    Shawi, M.
    Han, C.
    Rampakakis, E.
    Ostor, A. Andrew
    Mease, P. J.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1765 - 1765
  • [44] Long-term Efficacy of Guselkumab in Fatigue and Identification of Early Treatment Targets: Post Hoc Analysis Through 2 Years of a Phase 3, Randomized, Double-blind, Placebo-controlled Study Conducted in Biologic-naive Patients with Active Psoriatic Arthritis
    Gladman, Dafna
    Starr, Michael
    Ranza, Roberto
    Perdomo, Ana-Maria Bravo
    Strauss, Marcie
    Shawi, May
    Han, Chenglong
    Rampakakis, Emmanouil
    Ostor, Andrew
    Mease, Philip J.
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 4175 - 4178
  • [45] Long-term Efficacy of Guselkumab in Fatigue and Identification of Early Treatment Targets: Post Hoc Analysis Through 2 Years of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Conducted in Biologic-Naive Patients With Active Psoriatic Arthritis
    Gladman, Dafna
    Starr, Michael
    Ranza, Roberto
    Perdomo, Ana
    Strauss, Marcie
    Shawi, May
    Han, Chenglong
    Rampakakis, Emmanouil
    Ostor, Andrew
    Mease, Philip
    JOURNAL OF RHEUMATOLOGY, 2023, 50 (07) : 79 - 79
  • [46] Guselkumab in patients with active psoriatic arthritis who were biologic-naive or had previously received TNFα inhibitor treatment (DISCOVER-1): a double-blind, randomised, placebo-controlled phase 3 trial
    Deodhar, Atul
    Helliwell, Philip S.
    Boehncke, Wolf-Henning
    Kollmeier, Alexa P.
    Hsia, Elizabeth C.
    Subramanian, Ramanand A.
    Xu, Xie L.
    Sheng, Shihong
    Agarwal, Prasheen
    Zhou, Bei
    Zhuang, Yanli
    Ritchlin, Christopher T.
    LANCET, 2020, 395 (10230): : 1115 - 1125
  • [47] SECUKINUMAB PROVIDES RAPID AND SUSTAINED REDUCTIONS IN DACTYLITIS AND ENTHESITIS IN PATIENTS WITH PSORIATIC ARTHRITIS: ANALYSIS OF DATA FROM THE PHASE 3 RANDOMIZED, MULTICENTRE, DOUBLE-BLIND, PLACEBO-CONTROLLED FUTURE 2 STUDY
    Kirkham, Bruce
    Mease, Philip J.
    McInnes, Iain B.
    RHEUMATOLOGY, 2017, 56 : 77 - 77
  • [48] Tadalafil 5mg once daily for the treatment of Asian men with lower urinary tract symptoms secondary to benign prostatic hyperplasia: Analyses of data pooled from three randomized, double-blind, placebo-controlled studies
    Nishizawa, Osamu
    Yoshida, Masaki
    Takeda, Masayuki
    Yokoyama, Osamu
    Morisaki, Yoji
    Murakami, Masahiro
    Viktrup, Lars
    INTERNATIONAL JOURNAL OF UROLOGY, 2015, 22 (04) : 378 - 384
  • [49] EFFICACY OF GOLIMUMAB, A HUMAN ANTI-TNFα ANTIBODY, BY BASELINE CRP LEVEL IN PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS FROM THREE PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDIES
    Emery, Paul
    Genovese, Mark C.
    Fleischmann, Roy M.
    Matteson, Eric L.
    Hsia, Elizabeth C.
    Xu, Stephen
    Doyle, Mittie K.
    Rahman, Mahboob U.
    RHEUMATOLOGY, 2010, 49 : I101 - I101
  • [50] Lasmiditan for acute treatment of migraine in patients with cardiovascular risk factors: post-hoc analysis of pooled results from 2 randomized, double-blind, placebo-controlled, phase 3 trials
    Shapiro, Robert E.
    Hochstetler, Helen M.
    Dennehy, Ellen B.
    Khanna, Rashna
    Doty, Erin Gautier
    Berg, Paul H.
    Starling, Amaal J.
    JOURNAL OF HEADACHE AND PAIN, 2019, 20 (01):
12345